FDA Inspection 921540 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA completed an inspection of Boehringer Ingelheim Pharma GmbH & Co. KG on January 23, 2015 in Ingelheim am Rhein. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 23, 2015
- Fiscal Year
- 2015
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Ingelheim am Rhein (Germany)